Table 3.
Association of BP Status with Patient Characteristics*
| Normal blood pressure (n=114) |
Masked hypertension (n=70) |
Sustained hypertension (n=31) |
|
|---|---|---|---|
| Age**, years | 17.2 (14.4-20) | 17.4 (14.4-19.2) | 14.4 (10.3-16.5)a,b |
| Male Gender (%) | 64 (56) | 48 (69) | 19 (61) |
| African-American/Hispanic, n (%) | 20 (19) | 26 (40)a | 11 (44)a |
| Age at Transplantation**, years | 12.4 (8.4-16) | 12 (6.6-15.5) | 9 (5.7-12.6)a,b |
| Time post Transplantation**, years | 3.5 (1.1-7) | 3.9 (1.3-6.5) | 3 (1.4-9.6) |
| Acquired Glomerular Disease, n (%) | 27 (24) | 16 (23) | 8 (26) |
| Living Donors, n (%) | 69 (61) | 41 (59) | 16 (52) |
| Prior Dialysis, n (%) | 71 (63) | 48 (70) | 23 (74) |
| History of Rejection, n (%) | 30 (26) | 21 (30) | 9 (29) |
| Calcineurin Inhibitors, n (%) | 89 (80) | 58 (83) | 25 (86) |
| Steroids, n (%) | 45 (41) | 28 (40) | 18 (62)a,b |
| Overweight/Obese, n (%) | 36 (32) | 27 (39) | 14 (45) |
| Hemoglobin**, g/dL, | 12 (10.9-13) | 12.9 (11.6-13.6) | 11.7 (10.9-13.2) |
| Anemia, n (%) | 31 (27) | 11 (16) | 8 (26) |
| Treated for hypertension, n (%) | 74 (65) | 50 (71) | 25 (81) |
| ≥2 BP medications, n (%) | 22 (20) | 24 (34)a | 11 (35)a |
| LVMI (g/m2.7) § | 34 (30-40) | 37 (30-42) | 40 (35-48)a,b |
| LVH, n (%)§ | 21 (28) | 14 (33) | 11 (50)a |
| eGFR, Schwartz/CKD-EPI**
(ml/min/1.73m2) |
70 (55-92) | 69 (58-92) | 59 (45-78)a,b |
| eGFR <60 ml/min/1.73m2, n (%) | 43 (38) | 22 (31) | 16 (52) |
*
Characteristics of patients with WCH (n=6) are not presented due to the small number
**
Data are presented as median (IQR)
a
p<0.05 compared with normal BP
b
p<0.05 versus masked HTN
§
139 patients had echo results available for analysis